[Methylnaltrexone for opioid-induced constipation in cancer treatment]
Movik E, Ringerike T, Linnestad KK, Hofmann, B, Harboe I, Klemp M
Record ID 32010001789
English, Norwegian
Authors' recommendations:
Our review suggests that methylnaltrexone was more effective than placebo in terms of time to laxation. From an ethical point of view methylnaltrexone may contribute to help a vulnerable patient group and professionals in everyday care. Our health economic model nevertheless does not provide us with the grounds to conclude that the drug is cost-effective.
Details
Project Status:
Completed
Year Published:
2009
URL for published report:
n/a
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Norway
MeSH Terms
- Opioid-Induced Constipation
- Naltrexone
- Neoplasms
Contact
Organisation Name:
Norwegian Institute of Public Health
Contact Address:
Universitetsgata 2, Postbox 7004 St. Olavs plass, NO-0310 Oslo NORWAY. Tel: +47 23 25 50 00; Fax: +47 23 25 50 10;
Contact Name:
Berit.Morland@nokc.no, dagny.fredheim@nokc.no
Contact Email:
Berit.Morland@nokc.no, dagny.fredheim@nokc.no
Copyright:
<p>The Norwegian Knowledge Centre for the Health Services</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.